MMED MiniMed Group, Inc. - Common Stock

NAS · US · Healthcare · Medical Instruments & Supplies · minimed.com

19.70USD+0.51%Mkt Cap: 5.54B $P/E: —3d ago

MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Societe anonyme

$71.20BUSDP/E 26.7

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech

$22.02BUSDP/E 69.2

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.20BUSDP/E 71.6

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap5.54B USD

Enterprise Value5.39B USD

Revenue (TTM)3.22B USD

Gross Profit1.68B USD

Net Income (TTM)-333.00M USD

Revenue/Share12.22 USD

Last Price19.70 USD

Fiscal Year EndApr 2026

MR QuarterJul 2026

Employees8.0K

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)30.87

PEG—

EV/EBITDA18.86

EV/Revenue1.67

P/S1.72

P/B1.53

EPS (TTM)-1.53

EPS (Forward)0.64

52W Range

10.6566% of range24.43

52W High24.43 USD

52W Low10.65 USD

Profitability

Gross Margin54.16%

Oper. Margin0.47%

EBITDA Margin8.88%

Profit Margin-10.74%

ROE-9.22%

ROA-7.19%

Growth

Revenue Growth16.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-197.00M USD

CapEx (TTM)223.00M USD

FCF Margin—

FCF Yield—

Net Debt-148.00M USD

Net Debt/EBITDA-0.52

Balance Sheet

Debt/Equity0.04

Current Ratio1.81

Quick Ratio1.26

Book Value/Sh12.87 USD

Cash/Share0.74 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)24.92 USD

Upside (mean)+26.5%

Target Range15.00 USD – 29.00 USD

15.00+26.5% to mean29.00

# Analysts12

Ownership

Shares Out.281.35M

Float28.47M

Insiders89.92%

Institutions13.57%

Short Interest

Short Ratio6.4d

Short % Float47.64%

Short % Out.4.83%

Shares Short13.59M

Short (prev mo.)5.90M

Technical

SMA 5020.33 (-3.1%)

SMA 20016.32 (+20.7%)

Beta—

S&P 52W Chg14.58%

Avg Vol (30d)2.78M

Avg Vol (10d)3.37M

Technical Indicators

RSI (14)40.8

MACD-0.2461

MACD Signal0.1039

MACD Hist.-0.3500

BB Upper23.86 USD

BB Middle21.35 USD

BB Lower18.84 USD

BB Width23.50%

ATR (14)0.8946 USD

Vol Ratio (20d)1.57x